North Star Asset Management’s Akero Therapeutics AKRO Stock Holding History

North Star Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,700	Closed	-$271K	–	350
2025 Q3	$271K	Hold	5,700	–	–	0.01%	297
2025 Q2	$304K	Buy	+5,700	New	+$259K	0.01%	275

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

North Star Asset Management's AKRO Position: Q4 2025 in Review

North Star Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 5,700 shares — an estimated $271K sold.

North Star Asset Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $304K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

North Star Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
North Star Asset Management sold 5,700 Akero Therapeutics shares in Q4 2025, an estimated $271K.
North Star Asset Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
North Star Asset Management's Akero Therapeutics position peaked at $304K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on North Star Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.